[Iatrogenic extrapyramidal disorders]

Area of Science:

• Neuropharmacology
• Movement Disorders
• Clinical Neurology

Context:

• Extrapyramidal disturbances are common adverse effects of various medications.
• Cerebral dopaminergic pathways are frequently implicated in these drug-induced movement disorders.
• Neuroleptic drugs are a significant class associated with these side effects.

Purpose:

• To review the mechanisms and clinical presentations of drug-induced extrapyramidal disturbances.
• To highlight the role of dopaminergic interference in these conditions.
• To discuss specific syndromes including Parkinsonism, dystonia, dyskinesia, and neuroleptic malignant syndrome.

Summary:

• Drug-induced extrapyramidal disturbances primarily result from interference with cerebral dopaminergic mechanisms.
• Neuroleptics are a major class of drugs causing these movement disorders.
• The review details Parkinson's syndrome, acute dystonia, late-onset dyskinesia, and malignant neuroleptic syndrome.

Impact:

• Enhances understanding of drug-induced movement disorders for clinicians.
• Informs differential diagnosis of extrapyramidal symptoms.
• Provides a basis for managing and preventing these adverse drug reactions.